Artemis Medicare Services Limited

NSE: ARTEMISMED

49

total announcements

ARTEMISMED.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 11 Nov 2026

P/E (TTM)

134.7

P/E (Forward)

26.1

EPS (TTM)

₹2.29

52W Low

₹203.35

52W High

₹378.80

Beta

0.40

Price / Book

4.9

Return on Equity

12.21%

Debt / Equity

32.5

Revenue (TTM)

₹1,150 Cr

Gross Margin

22.66%

Operating Margin

12.96%

NSEAnalysts/Institutional Investor Meet/Con. Call Updates7h ago

Artemis Medicare Services Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Artemis Medicare Services Limited has informed the Exchange about an Analysts/Institutional Investors Conference scheduled for November 17, 2026, at JM Financial Annual India Conference in Mumbai.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults6d ago

Artemis Medicare Services Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Artemis Medicare Services Limited has informed the Exchange about Transcript of Earnings Conference Call - Q2 and H1 FY27. The company's consolidated revenue from operations for Q2 FY27 was INR 311 crores, representing year-on-year growth of 13.2%. Profit after tax for the quarter was INR 31 crore, representing a year-on-year growth of 3.7%. The company's focus remains on better utilization of clinical capacity, managing operational costs, and improving the contribution from specialized procedures.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults31 Oct 2026

Artemis Medicare Services Limited

Copy of Newspaper Publication

Artemis Medicare Services Limited has informed the Exchange about the publication of un-audited financial results for the quarter and half year ended September 30, 2026, in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
NSEMonitoring Agency ReportFundraise30 Oct 2026

Artemis Medicare Services Limited

Monitoring Agency Report

Artemis Medicare Services Limited has received a Monitoring Agency Report for the quarter ended September 30, 2026, from CARE Ratings Limited, which has found no deviation from the objects of the Preferential Issue of ₹330 crore.

Read more →📎 1 attachment
NSEInvestor PresentationResults30 Oct 2026

Artemis Medicare Services Limited

Investor Presentation

Artemis Medicare Services Limited has informed the Exchange about Investor Presentation for Q2 and H1 FY 27, highlighting its business overview, roadmap ahead, synergies, CSR initiatives, and ESG highlights.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults30 Oct 2026

Artemis Medicare Services Limited

Press Release

Artemis Medicare Services Limited has announced its Q2 FY27 financial results, with consolidated revenue from operations up 13.2% year-on-year, and adjusted EBITDA up 22.7%. The company's Gurugram operations recorded revenue growth of 14.5% year-on-year, with improved occupancy and operating profitability.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults30 Oct 2026

Artemis Medicare Services Limited

Outcome of Board Meeting

Artemis Medicare Services Limited has submitted its un-audited financial results for the quarter ended September 30, 2026, with the Board of Directors approving the results at its meeting held on October 30, 2026.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults27 Oct 2026

Artemis Medicare Services Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Artemis Medicare Services Limited has informed the Exchange about the schedule of Earnings Conference Call for Q2 and H1 FY27, to be held on November 2, 2026.

Read more →📎 1 attachment
NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the CompanyLitigation29 Sept 2026

Artemis Medicare Services Limited

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Artemis Medicare Services Limited has received a Show Cause Notice from the Office of the Assistant Commissioner, CGST, Gurugram regarding alleged non-payment of GST on medicines, consumables, and implants supplied to in-patients. The company has filed a writ petition before the Hon'ble High Court of Punjab & Haryana, Chandigarh, and is in the process of filing another writ to connect the matter with the previous one.

Read more →📎 1 attachment
NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the CompanyLitigation29 Sept 2026

Artemis Medicare Services Limited

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Artemis Medicare Services Limited has received a Show Cause Notice from the Office of the Assistant Commissioner, CGST, Gurugram regarding alleged non-payment of GST on medicines, consumables, and implants supplied to in-patients. The company has filed a writ petition before the Hon'ble High Court of Punjab & Haryana, Chandigarh, and is in the process of filing another writ to connect the matter with the previous one.

Read more →📎 1 attachment
NSETrading Window28 Sept 2026

Artemis Medicare Services Limited

Trading Window

Artemis Medicare Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Read more →📎 1 attachment
NSECredit RatingRating Change24 Sept 2026

Artemis Medicare Services Limited

Credit Rating

Artemis Medicare Services Limited has informed the Exchange about the reaffirmation of its credit rating by CARE Ratings Limited, with a stable outlook for its long-term bank facilities and short-term bank facilities.

Read more →📎 1 attachment
NSECopy of Newspaper Publication15 Sept 2026

Artemis Medicare Services Limited

Copy of Newspaper Publication

Artemis Medicare Services Limited has published a newspaper advertisement regarding the opening of a special window for transfer and dematerialisation of physical securities, as per SEBI regulations.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesMgmt Change8 Sept 2026

Artemis Medicare Services Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Artemis Medicare Services Limited has informed the Exchange about an Analysts/ Institutional Investors Conference scheduled for September 22, 2026, at the Anand Rathi Annual Flagship Conference in Mumbai.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026

Artemis Medicare Services Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Artemis Medicare Services Limited has informed the Exchange about Transcript of Earnings Conference Call - Q1 FY27. The company's consolidated revenue from operations for the quarter was at INR 287.32 crores, reflecting a year-on-year growth of 12.7% on a consolidated basis, and standalone year-on-year Gurgaon showed a top-line growth of 15.4%. The performance was supported by sustained demand across key specialties, particularly cardiology, oncology, neurosciences, and orthopedics, along with continued improvement in case mix and higher contribution from complex procedures.

Read more →📎 1 attachment
Page 1 of 3Next →